Kuntai Capsule

Shop Now

Overview

What is Kuntai Capsule?

Kuntai Capsule is a 6-ingredent Chinese herbal medicine formula for menopause related symptoms associated with yin deficiency and heat. Its traditional function is to nourish yin, clear heat, and calm the mind or relieve vexation.

Product Information

Chinese name坤泰胶囊
PinyinKuntai Jiaonang
BrandXintian
China Drug Approval No.Z20000083
Dosage formcapsule
Traditional functionNourishes yin, clears heat, and calms the mind or relieves vexation.
Strength0.5 g per capsule
Individual package0.5 g × 24 capsules
Recommended useLabeled for symptoms around menopause when the traditional pattern is yin deficiency with heat, including hot flushes, sweating, irritability, disturbed sleep, dizziness, tinnitus, lower-back and knee soreness, and heat in the palms or soles.
GTIN6922606800263

Main ingredients: Prepared rehmannia root, Coptis rhizome, White peony root, Scutellaria root, Donkey-hide gelatin, Poria

Evidence at a Glance

Human studies and systematic reviews have evaluated the same named finished formula for perimenopausal symptoms. Important limitations include open-label design in a principal trial and low methodological quality across many earlier trials; the evidence does not establish equivalence to hormone therapy or suitability for every menopause-related condition.

Do not use if you have a yang-deficiency constitution according to the product label; this traditional pattern should be assessed by a qualified practitioner.

Uses

Common Uses

Kuntai Capsule is used for menopause with symptoms like hot flashes, facial flushing, daytime sweating or night sweats, irritability, sleep problems, dizziness, ringing in the ears, lower-back or knee soreness, or a feeling of heat in the palms or soles.

Traditional & Labeled Uses

滋阴清热，安神除烦

Nourishes yin, clears heat, and calms the mind or relieves vexation

  • Hot flushes or facial flushing within the labeled traditional pattern
  • Spontaneous sweating or night sweating within the labeled traditional pattern
  • Irritability or disturbed sleep within the labeled traditional pattern
  • Dizziness, tinnitus, or lower-back and knee soreness within the labeled traditional pattern
  • Heat in the palms or soles within the labeled traditional pattern

A labeled traditional use describes the medicine’s approved context. It does not establish that the product restores ovarian reserve, treats infertility, prevents menopause-related health outcomes, or replaces hormone therapy or other clinician-directed care.

Understanding the TCM Perspective

Yin deficiency with heat is a Traditional Chinese Medicine pattern term. It is not direct biomedical diagnoses and should not be used to self-diagnose menopause, primary ovarian insufficiency, thyroid disease, anxiety, or another condition.

Kuntai Capsule is an over-the-counter (OTC) medicine in China. This Learn information is for educational purposes only. Always consult a healthcare provider before starting TCM treatments.

Safety

Pregnancy

Specific pregnancy safety information was not identified in the reviewed label record. Absence of a listed warning is not evidence of safety; seek advice from a clinician or pharmacist before use during pregnancy or when trying to conceive.

Allergy

Do not use if you are allergic to Kuntai Capsule or any listed ingredient. Stop use and seek urgent help for swelling, wheezing, trouble breathing, or another severe allergic reaction.

Breastfeeding

Specific breastfeeding safety information was not identified in the reviewed label record. Consult a clinician or pharmacist before use while breastfeeding.

Younger Users

The reviewed label record states that children should use the medicine only under adult supervision. Product-specific pediatric efficacy and safety data were not identified, and the labeled use concerns menopause-related presentations.

Drug Interactions

The reviewed product information does not identify specific established interaction pairs. It warns that interactions may occur with other medicines and advises consulting a physician or pharmacist before combined use. Do not change prescribed hormone therapy or other medicines without professional advice.

When to Seek Medical Advice

Seek medical review if symptoms have not improved after two weeks, if an adverse reaction occurs, or if symptoms are severe, persistent, or could have another cause. Follow the current physical package and professional advice.

Contraindications

  • Do not use if you have a yang-deficiency constitution according to the product label.
  • Do not use if you are allergic to Kuntai Capsule or any listed ingredient.

Reported Adverse Reactions

  • Occasional abdominal bloating
  • Occasional stomach pain

Evidence

Human Clinical Evidence

  • Kuntai Capsule compared with hormone therapy

    Design: Randomized controlled trial

    Year: 2018

    Sample size: 390

    Both groups improved from baseline. Most end-of-treatment group comparisons were not statistically different; hormone therapy improved hot-flush scores more, and fewer adverse events were reported in the Kuntai group.

    View reference ↓

  • Systematic review of Kuntai Capsule for menopausal syndrome

    Design: Systematic review

    Year: 2016

    Sample size: 1455

    The review found no statistically significant differences from hormone replacement therapy for several reported outcomes and fewer reported adverse events with Kuntai Capsule.

    View reference ↓

  • Kuntai Capsule versus hormone therapy: systematic review

    Design: Systematic review

    Year: 2017

    Sample size: 1243

    Several comparisons were not statistically significant, other measures differed, and fewer adverse events were reported with Kuntai Capsule.

    View reference ↓

Verification

PRODUCT IDENTITY

Brand Name
Xintian
Chinese Name
新天
Manufacturer
Guiyang Xintian Pharmaceutical Co., Ltd.
China drug approval number
Z20000083
Prescription status in China
Over-the-counter medicine.

These are Chinese product-registration details. They do not establish approval or availability in another country.

Verified by the AuthHerb Verification Team

  • Brand relationship confirmed
  • Manufacturer legal name confirmed
  • Approval number confirmed
  • Current packaging matched
  • Registration holder / manufacturer checked
  • Authenticity method checked
  • Label/source evidence recorded

Ingredients

This product contains the following ingredients:

Official Label Dosage

Take 4 capsules by mouth 3 times daily.

Follow the current package insert if its instructions differ.

Individual package: 0.5 g × 24 capsules

Missed Dose Information

No product-specific missed-dose instruction was identified.

Additional Directions

The reviewed label states that one course is 2–4 weeks, or as directed by a clinician.

Each capsule contains 0.5 g. Follow the current physical package and consult a clinician before extending treatment beyond the labeled course.

A purchase option’s quantity does not define how long you should take the medicine.

Review cautions and when to seek medical advice

Frequently Asked Questions About Kuntai Capsule

References

  1. [1]Kuntai Capsule compared with hormone therapyrandomized_controlled_trialChinese Journal of Integrative Medicine · 2018

    Population: 390 women aged 40–60 years with perimenopausal syndromes recruited at four clinical centers.

    Indication: Perimenopausal syndrome

    Intervention: Heyan Kuntai Capsule for 12 months.

    Comparison: Conjugated estrogen with or without medroxyprogesterone acetate for 12 months.

    Sample size: 390

    Duration: 12 months

    Reported findings

    Both groups improved from baseline. Most end-of-treatment group comparisons were not statistically different; hormone therapy improved hot-flush scores more, and fewer adverse events were reported in the Kuntai group.

    Interpretation

    This multicenter randomized trial provides direct human evidence for the same named finished formula in perimenopausal women.

    Limitations

    Open-label design, active rather than placebo comparator, and a selected trial population; non-significant differences do not establish equivalence.

    Sun AJ, Wang YP, Gu B, et al. A Multi-center, Randomized, Controlled and Open Clinical Trial of Heyan Kuntai Capsule and Hormone Therapy in Perimenopausal Women. Chinese Journal of Integrative Medicine. 2018;24(7):487–493. doi:10.1007/s11655-016-2266-y. PMID:27650094.

    Study type: randomized_controlled_trial

    PMID: 27650094

    DOI: 10.1007/s11655-016-2266-y

  2. [2]Systematic review of Kuntai Capsule for menopausal syndromesystematic_reviewComplementary Therapies in Medicine · 2016

    Population: 17 randomized trials with 1,455 participants with menopausal syndrome.

    Indication: Menopausal syndrome

    Intervention: Kuntai Capsule.

    Comparison: Placebo or hormone replacement therapy, depending on the included trial.

    Sample size: 1455

    Duration: 17 randomized trials

    Reported findings

    The review found no statistically significant differences from hormone replacement therapy for several reported outcomes and fewer reported adverse events with Kuntai Capsule.

    Interpretation

    This review synthesizes randomized evidence for Kuntai Capsule across relevant menopause-related outcomes.

    Limitations

    The included trials were judged to be of low methodological quality, limiting certainty.

    Zhou Q, Tao J, Song H, et al. Chinese herbal medicine Kuntai capsule for treatment of menopausal syndrome: a systematic review of randomized clinical trials. Complementary Therapies in Medicine. 2016;29:63–71. doi:10.1016/j.ctim.2016.09.011. PMID:27912959.

    Study type: systematic_review

    PMID: 27912959

    DOI: 10.1016/j.ctim.2016.09.011

  3. [3]Kuntai Capsule versus hormone therapy: systematic reviewsystematic_reviewJournal of Traditional Chinese Medicine · 2017

    Population: 15 randomized trials involving 1,243 patients with perimenopausal syndrome.

    Indication: Perimenopausal syndrome

    Intervention: Kuntai Capsule for at least three months.

    Comparison: Hormone replacement therapy.

    Sample size: 1243

    Duration: 15 randomized trials

    Reported findings

    Several comparisons were not statistically significant, other measures differed, and fewer adverse events were reported with Kuntai Capsule.

    Interpretation

    This review provides additional human comparative evidence for Kuntai Capsule in perimenopausal populations.

    Limitations

    Abstract-level reporting and underlying trial quality do not establish clinical equivalence or suitability for individual treatment decisions.

    Du X, Xu L, Wang L, et al. Comparison of the effect and safety of Kuntai capsule and hormone replacement therapy in patients with perimenopausal syndrome: a systematic review and meta-analysis. Journal of Traditional Chinese Medicine. 2017;37(3):279–285. PMID:31682369.

    Study type: systematic_review

    PMID: 31682369

  4. [4]Kuntai capsule for the treatment of diminished ovarian reserve: a systematic review and meta-analysis of randomized controlled trialssystematic_reviewJournal of Ethnopharmacology · 2024

    Zhang X, Zhang L, Xiong L, et al. Kuntai capsule for the treatment of diminished ovarian reserve: a systematic review and meta-analysis of randomized controlled trials. Journal of Ethnopharmacology. 2024;329:118167. doi:10.1016/j.jep.2024.118167. PMID:38593964.

    Study type: systematic_review

    PMID: 38593964

    DOI: 10.1016/j.jep.2024.118167